作者: Kevin P Bateman
关键词: Disease 、 Coronavirus disease 2019 (COVID-19) 、 Clinical trial 、 2019-20 coronavirus outbreak 、 Intensive care medicine 、 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 、 Medicine 、 Dried blood 、 Sampling (medicine) 、 Patient centric
摘要: Accessing patient samples using a whenever/wherever paradigm is needed to enable a better understanding of human biology and disease. The technology for convenient self-collection of blood samples by patients at home is quickly becoming available. The potential benefits of patient-centric sampling far outweigh the short-term challenges associated with implementation of this disruptive approach. This is especially true given we are amid a global pandemic and enabling patients to sample at home would help not only clinical trials …